NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹345 Cr | ₹189 Cr | ₹122 Cr | ₹147 Cr | ₹180 Cr |
What is the latest Total Non-Current Liabilities ratio of NEULAND LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹345 Cr |
| Mar2025 | ₹189 Cr |
| Mar2024 | ₹122 Cr |
| Mar2023 | ₹147 Cr |
| Mar2022 | ₹180 Cr |
How is Total Non-Current Liabilities of NEULAND LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹345 Cr | 82.41 | |
| Mar2025 | ₹189 Cr | 55.02 | |
| Mar2024 | ₹122 Cr | -16.73 | |
| Mar2023 | ₹147 Cr | -18.42 | |
| Mar2022 | ₹180 Cr | - | |
Compare Total Non-Current Liabilities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹25,554.8 Cr | 3.9% | 5.6% | 39.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 3.9% |
5.6% |
39.3% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses